Clinical trial
Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1…
NCT00063128 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00063128 |
|---|---|
| Title | Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus. |
| Official title | Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Alkermes, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | insulin, human insulin inhalation powder (HIIP) |
| Enrollment | 119 |
| Start date | Apr 1, 2003 |
| Completion | Apr 1, 2004 |
| First posted | Jun 25, 2003 |
| Last update posted | Dec 21, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: